Researchers looked specifically at participants aged 40 to 70 (average age 54.5) and asked a question nobody had really nailed down: what does lifetime cannabis use actually do to the brain once you're past the age everyone loves to study — the twentysomething brain that's still finishing construction?

I'm an old school stoner. I was here before legalization was a punchline on late-night television, before dispensaries had loyalty programs, before anybody put a leaf on a billboard. I remember when this plant could cost you your kids, your job, your freedom, your life, and people smoked it anyway, because some things are worth the risk. So when I hear rumblings about reversing course, about reclassifying, recriminalizing, rebuilding the machinery of the drug war one quiet regulation at a time, I don't feel panic. I feel something closer to recognition. We've been here before. We know how this goes.

Let's start with the headline nobody in Washington wants to print: marijuana is still illegal. Not "illegal-ish." Not "illegal with an asterisk." Federally, under the Controlled Substances Act, cannabis remains a Schedule I narcotic, officially grouped with heroin and LSD, officially declared to have no accepted medical use. That fact hasn't moved an inch this year, despite a summer's worth of DEA hearings, legal filings, and breathless coverage suggesting otherwise.

A rolling reserve on a high-risk account holds 5% to 10% of every sale for as long as 180 days. For a CBD merchant, that money is real revenue kept out of reach, and a single processor decision can turn a slow hold into a full freeze overnight. The freeze is rarely random. It follows a mistake the merchant made weeks earlier and never saw as dangerous.

For years, the cannabis world has treated "the entourage effect" like settled science, a comforting shorthand for why whole-plant weed hits different than an isolated THC pill. Terpenes and cannabinoids work together, the story goes, adding up to more than the sum of their parts. It's a nice idea. It's also, according to a new pre-proof study headed for the journal Biochemical Pharmacology, an oversimplification that's been doing a lot of unearned work in how we talk about cannabis.

The Washington State Department of Health just published a health advisory for FIFA World Cup visitors. It includes the standard warnings: start low, go slow, don’t drive, don’t mix with alcohol, edibles can take three hours and last up to 24. It is responsible, accurate, and completely inadequate for anyone who has never encountered what’s on dispensary shelves here.

According to the National Survey on Drug Use and Health (NSDUH), past-year cannabis use among Americans 12 and older climbed from 11.0% in 2002 to 22.3% in 2024 — a 103% increase. Over roughly the same period, past-month alcohol use dropped from 51% to 46.6%, a 9% decline. These aren’t rounding errors. They represent one of the most significant substance-use shifts in modern American history, and it’s happening largely without a formal policy directing it. No public health campaign told people to put down the beer and pick up the joint. They did it on their own.

These days, cannabis has successfully permeated almost every field of medicine. This reflects the scientific interest that the plant has attracted over the past 20 years or so. It’s crazy to think that what was once a strictly prohibited body of research is now one of the quickest-growing fields in science. In fact, major universities, health centers, hospitals, and even governments around the world clamor to study weed’s therapeutic benefits.

I know. You’re tired of hearing about AI. Half your feed is either someone gushing about their AI-generated side hustle or someone else losing their mind because a machine wrote a poem. The discourse has collapsed into two camps: the breathlessly optimistic and the chronically offended, and somehow neither side is saying anything useful about what’s actually happening.

Around 25, the ECS completes its development. The scaffolding comes down. Endocannabinoid production drops from the elevated levels of adolescence to adult maintenance levels — a significant reduction that shifts the entire baseline of the system.

The DEA announced the participants for its upcoming cannabis rescheduling hearing. June 2026. Momentous occasion, right? The machinery of federal government finally grinding toward something resembling justice for a plant that’s been federally prohibited for over fifty years.

Open source systems optimize for the function they actually perform, because anyone can see the code, find the bugs, propose improvements, and fork the project if the maintainers go sideways. The Linux kernel is more reliable than any proprietary operating system not because the people who built it were smarter, but because the model for building it is fundamentally superior.

Cathy O'Brien is a controversial figure. A survivor of what she claims was a CIA-connected mind control program called MK-Ultra, her testimony occupies the uncomfortable intersection between documented government abuse of citizens and conspiracy theory territory that most mainstream commentators prefer to dismiss wholesale.

Industrial hemp is a variety of Cannabis sativa L. cultivated specifically for non-psychoactive applications: fibre, seed, oil, and biomass. It contains less than 0.2% THC, the compound responsible for cannabis's psychoactive effects, which is the legal threshold the European Union applies to licensed cultivation. The crop is genetically and functionally distinct from marijuana in all commercially relevant ways.

Robinhood is a popular US-based investment app that allows everyday individuals to buy and sell stocks straight from their smartphones or computers. It offers commission-free trading not just of stocks but also ETFs, cryptocurrencies, options, and retirement accounts.

Start reading studies like a journalist rather than a supplicant. Find out who funded them, what products they actually tested, whether the blinding held, what the outcome measures were designed for, and when they were published relative to regulatory decisions they conveniently support. Most people who read the Wilson review headline stopped at the abstract. The abstract is where the playbook wants you to stop.

A greenhouse gives you better light and lower energy overhead. Add a properly designed hydroponic system, and you close the remaining performance gap between greenhouse and indoor yields. Hydroponics in a greenhouse context operates by delivering nutrient-rich water directly to the root zone, bypassing the inefficiencies of soil entirely.

Tyler Cowen published a piece in The Free Press recently asking whether we should recriminalize marijuana. He landed, sensibly, against it. The comment section of his blog filled up with the usual range: suburban homeowners insisting legalization ruined New York City, economists arguing about social norms, at least one guy who seems to think the solution to homelessness is making pot illegal again. The full spectrum of American cannabis discourse, in other words: heated, occasionally intelligent, and mostly beside the actual point.

The bill, passed with bipartisan support, would allow terminally ill patients to use medical marijuana for pain management even while hospitalized. That's the story. That's the bill. And somewhere in the machinery of American governance, enough people had enough reservations about this that it required an act of legislation to make it possible.

A recent study conducted by investigators at Yale University and the University of Oxford in the United Kingdom analyzed cognitive performance among lifetime weed users, then compared them to non-users in various aspects. They tested for memory, problem solving, and intelligence.

The latest version of this story comes from Virginia Commonwealth University, where researcher Emanuele Alves developed a portable, 3D-printed device shaped like an asthma inhaler that uses "Fast Blue" dye and gelatin cartridges to detect delta-9 THC in exhaled breath without requiring secondary lab analysis. The Justice Department provided funding. Marijuana Moment covered it. OregonLive called it "the marijuana breathalyzer police have been waiting for."

But there's more to this image than nostalgia and comedy. What you're looking at in that High Times spread is a snapshot of cannabis before genetics became an industry, before selection pressure from legalization narrowed the gene pool into a parade of similar high-THC cultivars, and before the concept of a "strain" meant something you could trademark and market to dispensary buyers. You're looking at the world cannabis came from. And understanding that world matters a great deal for where cannabis is going.

Reading through hundreds of grower responses, one theme emerges above the specific challenges: growing cannabis well requires learning to manage systems rather than react to crises. The best growers in the thread weren't the ones who had the best solutions to pest outbreaks or overwatering — they were the ones who had built systems stable enough that those crises rarely happened.

The finding: states that legalized medical or recreational marijuana saw significant reductions in non-fatal opioid overdoses. Access to medical cannabis dispensaries was associated with a 15.47 percent reduction in non-fatal opioid overdoses per 100,000 enrollees per quarter. Recreational legalization tracked to an 11.92 percent reduction. Among adults aged 18 to 34, the medical dispensary effect was even sharper — a 23.27 percent reduction.

Eighty-eight percent. Let that sit for a moment. According to the latest nationwide polling from Pew Research Center, released May 26, 2026, only one in ten American adults thinks cannabis should remain fully illegal. That's it. One in ten. The same fraction that still believes the Earth is flat, that cursive handwriting is essential life infrastructure, or that dial-up internet was fast enough.

Based on the findings of a recent preclinical study from the University of California, Riverside (UCR), researchers found that individuals who consumed cannabis for several years usually have a reduced risk of type 2 diabetes and lower body weight. These findings still confused them because of cannabis’s reputation for increasing one’s appetite.

The cannabis community has historically been full of creative people, entrepreneurs, tinkerers, and people who are comfortable thinking outside the frameworks that everyone else takes for granted. That is partly cultural, partly chemical, and largely the result of having spent years operating in spaces where the mainstream rules did not apply. That disposition is an asset right now.

A new study drops, and predictably, the headlines follow. Cannabis triples your lung cancer risk. Heavy users beware. Smoke at your peril. The coverage makes it sound like rolling a joint is roughly equivalent to gargling asbestos, and the average reader is left with one clear takeaway: marijuana will kill you.

There are many ways that the current wave of psychedelic research marks a dramatic breakthrough in society and culture: we no longer see these substances as recreational drugs, but powerful medicines in the realms of mental health, well-being, and neuroscience.

The Wall Street Journal's Future View recently asked college students whether marijuana should be legal. Several of them wrote thoughtful pieces. A few of them wrote arguments that collapse the moment you apply them consistently. I respect the exercise, and I respect that these are young people working through genuinely complex policy questions. But bad arguments don't improve with politeness, so let's get into it.

On May 14, 2026, the U.S. Army published an article titled 'Breaking Down Cannabinoids: How They Compromise Readiness.' The piece, written by two staffers from the Directorate of Prevention, Resilience and Readiness, runs through the standard arguments: cannabinoids impair judgment, Delta-8 can cause false positives, CBD is banned regardless of what your state law says, zero tolerance is the policy, full stop.

Vegan Delta 9 gummies are edible hemp-derived THC products made without animal-based ingredients. Traditional gummies often contain gelatin, which manufacturers usually source from animal collagen. Vegan gummies replace gelatin with plant-based alternatives like pectin, a natural fiber commonly derived from fruits.

The Trump administration had an opening. The hemp market proved the concept. The polling supported the move. The fiscal argument was there. Instead, the White House published a 195-page document that reads like it was written in 1988, invokes psychosis studies with contested methodology, and affirms the recriminalization of a $28 billion industry that was, by any reasonable measure, working.

Medical marijuana is becoming increasingly mainstream across the United States, with millions of patients now using cannabis to manage conditions such as chronic pain, anxiety, PTSD, insomnia, epilepsy, and cancer-related symptoms. But as legalization expands and dispensaries become easier to access, an important issue is getting lost in the excitement: physician guidance still matters.

Start with the most obvious one. The pharmaceutical industry loses, by some estimates, around $10 billion annually in markets where medical cannabis is legal. Patients substitute cannabis for opioids, sleep aids, anti-anxiety medications, and antidepressants. Not all patients, and not always — but enough to show up in the revenue reports.

When a brand describes its CBD flower as lab tested, that phrase should carry real weight but not all testing is created equal. The gold standard is third-party testing by an ISO-certified laboratory. Third-party means the lab has no financial relationship with the brand whose products it's testing.

The 2026 awards made one thing clear: growers are done with mystery clones from anonymous sellers. Get Seeds Right Here earned #1 because it gave growers the strongest overall package: catalog, reputation, ordering experience, and a clear long-term commitment to the cannabis clone space. The rest of the top five earned their spots doing the same work at a slightly smaller scale.

Chinese researchers at Shandong University just published a study in the Journal of Archaeological Science that does something straightforward: it tells the truth about cannabis's place in human history. Using phytolith analysis — the study of microscopic plant silica structures found in soil — the team examined 132 samples from two Late Neolithic settlements in the Shandong province. What they found was not marginal or incidental. Cannabis was one of the five grains.

So, are cannabis pens gaining ground in North America? The overall trend says yes. However, a more insightful question is why they are becoming more popular and what this reveals about the future of legal cannabis.

This is the legacy knowledge drain, and it is the quiet catastrophe nobody in the cannabis industry wants to talk about openly—because acknowledging it means acknowledging that the "professionalization" of weed has, in many respects, destroyed the thing that made it worth professionalizing.

The petrochemical industry that grew in hemp's absence now generates revenues in the tens of trillions annually across its downstream product chains—plastics, synthetic fibers, lubricants, paints, solvents, packaging, insulation, construction materials.

In the rapidly evolving world of cannabis, information is the most valuable currency. For years, platforms like Cannabis.net have served as the ultimate hub for enthusiasts, patients, and industry professionals to stay informed about legalization, medical breakthroughs, and market trends

Every two years, cannabis advocates wheel out the same ritual. Ballot measures, candidate endorsements, grasstops lobbying, NORML scorecards, press releases about historic progress. Every two years, a version of the same headline runs: "Cannabis Reform Reaches Tipping Point." Every two years, the people who believed it discover that the tipping point was a marketing event.

This makes us now ponder if the future of the marijuana industry will be handed over to Big Cannabis, as this move may capitalize on a huge financial shift (possibly the biggest one we’ve ever seen): quite possibly, it could signal the end of the 280E tax laws due to Schedule III reform.

That is a fair question. The 7OH market can be confusing, especially with so many tablets, shots, gummies, powders, Pseudo products, MIT products, MGM-15 products, and specialty alkaloid blends available online. Product names can sound similar, strengths can vary widely, and shoppers need more than flashy packaging to make a confident decision.

White House Press Secretary Karoline Leavitt described the rescheduling as something the president did 'at the behest of the American public, who largely support it.' That framing deserves scrutiny. The American public largely supports full federal legalization. They were given partial medical rescheduling. These are not the same thing, and the study makes that impossible to misread.

Here is where it breaks down. Section 2 of the application — the Activity section — asks applicants to specify which substances they handle. One of those questions asks whether your firm will be handling or dispensing recreational marijuana. If you answer yes, you are, by the federal government's own definition, admitting to trafficking a Schedule I controlled substance. On a federal form. With your name, address, Social Security number, and Tax ID attached.

Minnesota's Department of Health just released the latest results of its triennial Minnesota Student Survey, and the headline reads like a prohibitionist's nightmare: there has been a 57.7 percent statewide drop in self-reported past-year cannabis use from 2013 to 2025 among 8th, 9th, and 11th graders combined. "96 percent of students report not having used cannabis in the last month," the department said in its release. Gov. Tim Walz legalized adult-use cannabis in 2023, making this the first survey cycle conducted since the state ended prohibition.

She ordered from 10 seed banks over two years. Spent $1,000 of her own money. Tracked three things — germination rates, shipping reliability, and genetics quality — and wrote it all up without monetizing a single word of it. No affiliate links buried in the copy. No sponsored sections dressed up as opinions. Just notes from someone who got tired of hitting the same recycled listicles every time she searched "best seed banks" and decided to build the resource herself.

Per the White House's own fact sheet, the executive order does several things. It directs the FDA Commissioner to issue National Priority Vouchers to psychedelic drugs that have already received Breakthrough Therapy designation, which is meant to speed up the review process.